CAS-MPG Partner Institute and Key Laboratory for Computational Biology, Shanghai Institutes for BiologicalSciences, Chinese Academy of Sciences, Shanghai, China.
Hum Mol Genet. 2011 Feb 1;20(3):528-40. doi: 10.1093/hmg/ddq498. Epub 2010 Nov 16.
Genetic polymorphisms in many genes related to drug absorption, distribution, metabolism and excretion (ADME genes) contribute to the high heterogeneity of drug responses in humans. However, the extent to which genetic variation in ADME genes may contribute to differences among human populations in drug responses has not been studied. In this work, we investigate the global distribution of genetic diversity for 31 core and 252 extended ADME genes. We find that many important ADME genes are highly differentiated across continental regions. Additionally, we analyze the genetic differentiation associated with clinically relevant, functional polymorphism alleles, which is important for evaluating potential among-population heterogeneity in drug treatment effects. We find that ADME genes show significantly greater variation in levels of population differentiation, and we find numerous signals of recent positive selection on ADME genes. These results suggest that genetic differentiation at ADME genes could contribute to population heterogeneity in drug responses.
许多与药物吸收、分布、代谢和排泄(ADME 基因)相关的基因中的遗传多态性导致了人类对药物反应的高度异质性。然而,ADME 基因中的遗传变异在多大程度上可能导致人类对药物反应的人群差异尚未得到研究。在这项工作中,我们研究了 31 个核心和 252 个扩展的 ADME 基因的遗传多样性的全球分布。我们发现,许多重要的 ADME 基因在大陆区域之间存在高度分化。此外,我们还分析了与临床相关的、功能多态性等位基因相关的遗传分化,这对于评估药物治疗效果的潜在人群异质性非常重要。我们发现 ADME 基因在种群分化水平上表现出显著更大的变异,并且我们发现 ADME 基因上存在许多近期正选择的信号。这些结果表明,ADME 基因的遗传分化可能导致药物反应的人群异质性。